While Immunome Inc has underperformed by -3.84%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, IMNM rose by 73.59%, with highs and lows ranging from $30.96 to $6.93, whereas the simple moving average fell by -13.20% in the last 200 days.
On November 08, 2024, Stephens started tracking Immunome Inc (NASDAQ: IMNM) recommending Overweight. A report published by Piper Sandler on May 31, 2024, Initiated its previous ‘Overweight’ rating for IMNM. JP Morgan also rated IMNM shares as ‘Overweight’, setting a target price of $24 on the company’s shares in an initiating report dated April 30, 2024. Guggenheim Initiated an Buy rating on April 15, 2024, and assigned a price target of $35. Leerink Partners initiated its ‘Outperform’ rating for IMNM, as published in its report on January 29, 2024. Wedbush’s report from December 19, 2023 suggests a price prediction of $12 for IMNM shares, giving the stock a ‘Outperform’ rating. Cantor Fitzgerald also rated the stock as ‘Overweight’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Immunome Inc (IMNM)
Further, the quarter-over-quarter decrease in sales is -18.37%, showing a negative trend in the upcoming months.
Immunome Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -276.36% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 6.17, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and IMNM has an average volume of 773.66K. On a monthly basis, the volatility of the stock is set at 7.86%, whereas on a weekly basis, it is put at 8.58%, with a gain of 21.43% over the past seven days. Furthermore, long-term investors anticipate a median target price of $30.00, showing growth from the present price of $13.54, which can serve as yet another indication of whether IMNM is worth investing in or should be passed over.
How Do You Analyze Immunome Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As opposed to executive stock, institutional ownership accounts for 82.32% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
IMNM shares are owned by institutional investors to the tune of 82.32% at present.
